The New Political Economy Of Pharmaceuticals PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The New Political Economy Of Pharmaceuticals PDF full book. Access full book title The New Political Economy Of Pharmaceuticals.

The New Political Economy of Pharmaceuticals

The New Political Economy of Pharmaceuticals
Author: Hans Löfgren
Publisher: Springer
Total Pages: 282
Release: 2016-04-30
Genre: Political Science
ISBN: 1137315857

Download The New Political Economy of Pharmaceuticals Book in PDF, ePub and Kindle

Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.


Medical Research for Hire

Medical Research for Hire
Author: Jill A. Fisher
Publisher:
Total Pages: 280
Release: 2009
Genre: Clinical trials
ISBN:

Download Medical Research for Hire Book in PDF, ePub and Kindle

Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because they offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care. A volume in the Critical Issues in Health and Medicine series, edited by Rima D. Apple and Janet Golden


Drugs, Crime and Public Health

Drugs, Crime and Public Health
Author: Alex Stevens
Publisher: Routledge
Total Pages: 216
Release: 2010-10-04
Genre: Law
ISBN: 1136918205

Download Drugs, Crime and Public Health Book in PDF, ePub and Kindle

Drugs, Crime and Public Health provides an accessible but critical discussion of recent policy on illicit drugs. Using a comparative approach - centred on the UK, but with insights and complementary data gathered from the USA and other countries - it argues that problematic drug use can only be understood in the social context in which it takes place.


Political Economy of Illegal Drugs

Political Economy of Illegal Drugs
Author: Pierre Kopp
Publisher: Routledge
Total Pages: 426
Release: 2003-11-20
Genre: Business & Economics
ISBN: 1134487444

Download Political Economy of Illegal Drugs Book in PDF, ePub and Kindle

With debates surrounding the decriminalisation of certain illegal drugs raging in many countries around the world, this new book is a timely and sober reflection on one of the biggest social problems facing the world at large. Of interest not only to economists, but also to criminologists and those involved in policy-making, The Economics of Illega


Medical Research for Hire

Medical Research for Hire
Author: Jill A. Fisher
Publisher: Rutgers University Press
Total Pages: 273
Release: 2008-11-06
Genre: Medical
ISBN: 0813545935

Download Medical Research for Hire Book in PDF, ePub and Kindle

Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because they offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care. A volume in the Critical Issues in Health and Medicine series, edited by Rima D. Apple and Janet Golden


The Political Economy of Narcotics

The Political Economy of Narcotics
Author: Julia Buxton
Publisher: Bloomsbury Publishing
Total Pages: 257
Release: 2008-02-29
Genre: Social Science
ISBN: 1848131615

Download The Political Economy of Narcotics Book in PDF, ePub and Kindle

This book explores the origins, history and organisation of the international system of narcotic drug control with a specific focus on heroin, cannabis and cocaine. It argues that the century-long quest to eliminate the production, trade in and use of narcotic drugs has been a profound failure. The statistics produced by the international and domestic narcotic drug control agencies point to a sustained expansion of the drug trade, despite the imposition of harsh criminal sanctions against those engaged, as producers, traffickers or consumers, in the narcotic drugs market. The roots of this major international policy failure are traced back to the outdated ideology of prohibition, which is shown to be counterproductive, utopian and a fundamentally inadequate basis for narcotic drug policy in the twenty-first century. Prohibition, championed by many US policy makers, has left the international community poorly positioned to confront those changes to the drug trade and drug markets that have resulted from globalisation. Moreover, prohibition based approaches are causing more harm than good, as is demonstrated through reference to issues such as HIV/AIDS, the environment, conflict, development and social justice. As the drug control system approaches its centenary, there are signs that the global consensus on narcotic drug prohibition is fracturing. Some European and South American states are pushing for a new approach based on regulation, decriminalisation and harm reduction. But those seeking to revise prohibition strategies faces entrenched resistance, primarily by the U.S. This important text argues that successive American governments have pursued a contradictory approach; acting decisively against the narcotic drug trade at home and abroad, while at the same time working with drug traffickers and producer states when it is in America's strategic interest. As a result, US policy approaches emerge as a decisive factor in accounting for the failure of prohibition.


Making Medicines in Africa

Making Medicines in Africa
Author: Maureen Mackintosh
Publisher: Springer
Total Pages: 353
Release: 2016-02-03
Genre: Political Science
ISBN: 1137546476

Download Making Medicines in Africa Book in PDF, ePub and Kindle

This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details.


Coalitions and Compliance

Coalitions and Compliance
Author: Kenneth C. Shadlen
Publisher: Oxford University Press
Total Pages: 263
Release: 2017-08-04
Genre: Political Science
ISBN: 019253484X

Download Coalitions and Compliance Book in PDF, ePub and Kindle

Coalitions and Compliance examines how international changes can reconfigure domestic politics. Since the late 1980s, developing countries have been subject to intense pressures regarding intellectual property rights. These pressures have been exceptionally controversial in the area of pharmaceuticals. Historically, fearing the economic and social costs of providing private property rights over knowledge, developing countries did not allow drugs to be patented. Now they must do so, an obligation with significant implications for industrial development and public health. This book analyses different forms of compliance with this new imperative in Latin America, comparing the politics of pharmaceutical patenting in Argentina, Brazil, and Mexico. Coalitions and Compliance focuses on two periods of patent politics: initial conflicts over how to introduce drug patents, and then subsequent conflicts over how these new patent systems function. In contrast to explanations of national policy choice based on external pressures, domestic institutions, or Presidents' ideological orientations, this book attributes cross-national and longitudinal variation to the ways that changing social structures constrain or enable political leaders' strategies to construct and sustain supportive coalitions. The analysis begins with assessment of the relative resources and capabilities of the transnational and national pharmaceutical sectors, and these rival actors' efforts to attract allies. Emphasis is placed on two ways that social structures are transformed so as to affect coalition-building possibilities: how exporters fearing the loss of preferential market access may be converted into allies of transnational drug firms, and differential patterns of adjustment among state and societal actors that are inspired by the introduction of new policies. It is within the changing structural conditions produced by these two processes that political leaders build coalitions in support of different forms of compliance.


The Political Economy of Pharmaceutical Patents

The Political Economy of Pharmaceutical Patents
Author: Sherry S. Marcellin
Publisher: Routledge
Total Pages: 227
Release: 2016-02-24
Genre: Political Science
ISBN: 1317020804

Download The Political Economy of Pharmaceutical Patents Book in PDF, ePub and Kindle

This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.